Pacific Edge shares soar to 7-year high on United deal

Pacific Edge shares soar to 7-year high on United deal
Staff reporters
Pacific Edge shares rose to their highest level in about seven years after the bladder cancer diagnostics firm said its Cxbladder test is now approved by the biggest healthcare group in the US.The stock rose as high as $1.30 and was recently up 25.3% at $1.24 after a brief trading halt.Pacific Edge said from April 1 its bladder test is covered by a United Healthcare medical policy held by 5.7 million of its 50m members.“Gaining coverage with the US’s largest insurer is a significant achievement for Pacific Edge and will be of benefi...